HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.

Abstract
Ischemic myocardium exhibits inflammation, local angiotensin II (Ang II) generation and up-regulation of LOX-1, a lectin-like ox-LDL receptor. To define the inter-active roles of Ang II and inflammation in furthering tissue injury, cultured HL-1 cardiomyocytes were treated with Ang II. Ang II treatment up-regulated the expression of Ang II type 1 (AT1R) and type 2 (AT2R) receptors as well as LOX-1. Ang II also activated p44/42MAPK, p38MAPK, c-Jun and NF-κB, and increased the expression of inflammation-related genes (interleukins-6, interleukins-10, tumor necrosis factor-α, intercellular adhesion molecule-1). To study how inflammation per se might affect expression of Ang II receptors and LOX-1, cultured, cardiomyocytes were treated with lipopolysaccharide (LPS). Like Ang II, LPS increased the expression of AT1R, AT2R and LOX-1. LPS also activated mitogen-acticated protein kinase (MAPKs), c-Jun and NF-κB, and pro-inflammatory genes. The selective inhibitors of MAPKs, c-Jun and NF-κB each blocked the transcription of LOX-1 and pro-inflammatory genes in response to Ang II as well as LPS. These observations suggested a positive feedback between Ang II and inflammation. To delineate the role of AT1R and AT2R in LOX-1 expression, another set of cardiomyocytes were transfected with AT1R or AT2R cDNA. Forced over-expression of AT1R resulted in activation of MAPKs, c-Jun and NF-κB, up-regulation of inflammatory genes and LOX-1; on the other hand forced AT2R over-expression induced up-regulation of pro-apoptotic signals (pro-IL-1β and IL-1β), and decreased LOX-1 expression. These studies show that both Ang II and inflammation mediator LPS up-regulate AT1R, AT2R and LOX-1 expression. Up-regulation of AT1R promotes inflammation and LOX-1 expression, whereas up-regulation of AT2R promotes apoptosis signals and decreases LOX-1 expression.
AuthorsXianwei Wang, Magomed Khaidakov, Zufeng Ding, Sona Mitra, Jingjun Lu, Shijie Liu, Jawahar L Mehta
JournalExperimental biology and medicine (Maywood, N.J.) (Exp Biol Med (Maywood)) Vol. 237 Issue 12 Pg. 1394-401 (Dec 2012) ISSN: 1535-3699 [Electronic] England
PMID23354398 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cytokines
  • DNA, Complementary
  • Inflammation Mediators
  • Lipopolysaccharides
  • NF-kappa B
  • Olr1 protein, mouse
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Scavenger Receptors, Class E
  • Angiotensin II
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Angiotensin II (genetics, metabolism)
  • Animals
  • Apoptosis (drug effects, genetics)
  • Cell Line
  • Cytokines (biosynthesis, genetics)
  • DNA, Complementary (genetics)
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • Inflammation (genetics, metabolism, pathology)
  • Inflammation Mediators (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Mice
  • Myocytes, Cardiac (metabolism, pathology)
  • NF-kappa B (genetics, metabolism)
  • Receptor, Angiotensin, Type 1 (biosynthesis, genetics)
  • Receptor, Angiotensin, Type 2 (biosynthesis, genetics)
  • Scavenger Receptors, Class E (biosynthesis, genetics)
  • Signal Transduction (drug effects, genetics)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: